The gene p16 may also potentially be involved in the occurrence of these malignancies since it inhibits the cyclin‐dependent kinase CDK4 (CD4 K and CDKN2A being known melanoma susceptibility genes) and since some mutations of p16 were reported in different types of lymphoma.12 This evidence concerns the gene CDK4 and melanoma.